{"disease":{"id":"c-staged-hepatocellular-carcinoma-in-bclc-classification","name":"c staged hepatocellular carcinoma in bclc classification"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05313282","title":"A Trial of Hepatic Arterial Infusion Combined With Apatinib and Camrelizumab Versus Apatinib and Camrelizumab for C-staged Hepatocellular Carcinoma in BCLC Classification","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":140,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT04191889","title":"A Trial of Hepatic Arterial Infusion Combined With Apatinib and Camrelizumab for C-staged Hepatocellular Carcinoma in BCLC Classification","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":47,"lead_sponsor_name":"Sun Yat-sen University","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}